Clinical Trial Update: A Study of Ferric Citrate to Improve Inflammation and Lipid Levels [Phase 4]

View source ↗

Summary

Phase 4 trial of ferric citrate in end-stage renal disease assesses inflammation and lipid levels; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Hyperphosphatemia
• Inflammation

Drugs mentioned

• Ferric citrate (ferric citrate)

Snippet

Sponsor: Winthrop University Hospital | Conditions: End Stage Renal Disease, Hyperphosphatemia | Phase 4 | Status: TERMINATED | Results posted: 2023-04-20